Preventing coronary events by optimal control of blood pressure and lipids in patients with the metabolic syndrome

American Journal of Cardiology

Volumn 91, Issue 12, 2003, Pages 1421-1426

  Wong, Nathan D ^a   Pio, Jose R ^b   Franklin, Stanley S ^b   L'Italien, Gil J ^b   Kamath, Tripthi V ^b   Williams, G Rhys ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ALGORITHM; ARTICLE; BLOOD PRESSURE REGULATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY RISK; FEMALE; HEALTH EDUCATION; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; LIPID ANALYSIS; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; SEX RATIO; UNITED STATES;

EID: 0037526450     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(03)00392-8     Document Type: Article

References (9)

1. Deedwania P.C. Clinical significance of cardiovascular dysmetabolic syndrome. Curr Controll Trials Cardiovascular Med. 3:2002;1-5.
2. Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults findings from the third National Health and Nutrition Examination Survey . JAMA. 287:2002;356-359.
3. Isomaa B., Almgren P., Tuomi T., Forsen B., Lahti K., Nissen M., Taskinen M.R., Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diab Care. 24:2001;683-689.
4. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 285:2001;2486-2497.
5. The Sixth Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 157:1997;2413-2446.
6. Third Report on Nutrition Monitoring in the United States: Volume I. Washington, DC: US Government Printing Office, 1995.
7. Wilson P.W.F., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation. 97:1998;1837-1847.
8. Brown B.G., Albers J.J., Fisher L.D. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med. 323:1990;1289-1298.
9. Brown B.G., Zhao X.-Q., Chait A., Fisher L.D., Cheng M.C., Morse J.C., Dowdy A.A., Marino E.K., Golson E.L., Alaupovic P., Frohlich J., Albers J.J. Simvastatin, and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med. 345:2001;1583-1592.